CAS
CTC Alternative Strategies’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,944
| Closed | -$239K | – | 193 |
|
|
2025
Q1 | $239K | Buy |
+2,944
| New | +$239K | 0.29% | 75 |
|
|
2024
Q3 | – | Sell |
-13,000
| Closed | -$1.21M | – | 203 |
|
|
2024
Q2 | $1.21M | Buy |
+13,000
| New | +$1.21M | 0.51% | 47 |
|
|
2023
Q3 | – | Sell |
-2,850
| Closed | -$237K | – | 199 |
|
|
2023
Q2 | $237K | Buy |
+2,850
| New | +$237K | 0.3% | 106 |
|